"Jan. 22, 2013 -- Regular aspirin users are more likely to develop the "wet" form of age-related macular degeneration compared to people who rarely or never take the drug, a new study shows.
Aspirin is one of the most widely used drugs in th"...
Tobrex Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Tobrex (tobramycin ophthalmic ointment) is used to treat bacterial infections of the eyes. It is an antibiotic. This medication is available in generic form. Common side effects include temporary blurred vision, tearing, eye redness, eye discomfort, or eyelid itching/swelling.
Apply a half-inch ribbon dose of Tobrex into the affected eye(s) two or three times per day. In severe infections, instill a half-inch ribbon into the affected eye(s) every three to four hours until improvement. Do not use other eye drops or medications during treatment with Tobrex ophthalmic unless directed by your doctor. Other drugs may interact with Tobrex ophthalmic. Tell your doctor all medications you use. This medication should be used only when prescribed during pregnancy. It is unknown if this medication passes into breast milk. Consult your doctor before breast-feeding.
Our Tobrex (tobramycin ophthalmic ointment) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Patient Information in Detail?
Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.
Tobrex in Detail - Patient Information: Side Effects
Serious side effects are not expected with this medication.
Commonly, some eye burning, stinging, irritation, itching, redness, blurred vision, eyelid itching, eyelid swelling, or sensitivity to light may occur.
Read the entire detailed patient monograph for Tobrex (Tobramycin Ophthalmic Ointment) »
What is Patient Information Overview?
A concise overview of the drug for the patient or caregiver from First DataBank.
Tobrex Overview - Patient Information: Side Effects
Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.
Use of this medication for prolonged or repeated periods may result in a new fungal eye infection. Do not use it for longer than prescribed. Contact your doctor if you notice new or worsening symptoms.
A very serious allergic reaction to this drug is unlikely, but seek immediate medical attention if it occurs. Symptoms of a serious allergic reaction may include: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.
This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.
In the US -
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Read the entire patient information overview for Tobrex (Tobramycin Ophthalmic Ointment)»
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Tobrex FDA Prescribing Information: Side Effects
The most frequent adverse reactions to TOBREX (tobramycin ophthalmic ointment) 0.3% are hypersensitivity and localized ocular toxicity, including lid itching and swelling, and conjunctival erythema. These reactions occur in less than three of 100 patients treated with TOBREX (tobramycin ophthalmic ointment) 0.3%. Similar reactions may occur with the topical use of other aminoglycoside antibiotics. Other adverse reactions have not been reported from TOBREX (tobramycin ophthalmic ointment) 0.3% therapy; however, if topical ocular tobramycin is administered concomitantly with systemic aminoglycoside antibiotics, care should be taken to monitor the total serum concentration. In clinical trials, TOBREX (tobramycin ophthalmic ointment) 0.3% produced significantly fewer adverse reactions (3.7%) than did GARAMYCIN® Ophthalmic Ointment (10.6%).
Read the entire FDA prescribing information for Tobrex (Tobramycin Ophthalmic Ointment) »
Additional Tobrex Information
Tobrex - User Reviews
Tobrex User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Get breaking medical news.